Upgrade to SI Premium - Free Trial

Gilead Sciences (GILD) PT Lowered to $100 at Citi

February 5, 2019 6:59 AM
Citi analyst Robyn Karnauskas lowered the price target on Gilead Sciences (NASDAQ: GILD) to $100.00 (from $106.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst PT Change

Next Articles